You are here

  • Home
  • Archive
  • Volume 30, Issue 5
  • Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF
Original research
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

 

Online download statistics by month:

Online download statistics by month: February 2020 to December 2024

AbstractFullPdf
Feb 20207333
Mar 20205581512
Apr 202013363
May 2020668219
Jun 202090107
Jul 20209887
Aug 20207333
Sep 20206401
Oct 2020100115
Nov 20205142
Dec 2020127275
Jan 202118342
Feb 20215900
Mar 20216110
Apr 20216021
May 20212823
Jun 2021311
Jul 2021321
Aug 2021510
Sep 2021720
Oct 20214400
Nov 20213612
Dec 20214243
Jan 20227541
Feb 20226921
Mar 202213973
Apr 20224100
May 20228510
Jun 20225810
Jul 20227971
Aug 20228610
Sep 202210020
Oct 20227520
Nov 20224200
Dec 202210121
Jan 20235111
Feb 202313800
Mar 20233121
Apr 20236611
May 20237910
Jun 20232700
Jul 20231220
Aug 20234311
Sep 20233700
Oct 20233600
Nov 202310110
Dec 20239110
Jan 20244710
Feb 20249121
Mar 20244421
Apr 20247111
May 20247311
Jun 20248133
Jul 20244411
Aug 20245022
Sep 20243810
Oct 202410011
Nov 202411231
Dec 2024800
Total498718593